Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,170 | Dovepress* | 9,967+ | 861 | 10,828 | |
PubMed Central* | 2,203 | 500 | 2,703 | ||
Totals | 12,170 | 1,361 | 13,531 | ||
*Since 21 August 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar